Viewing Study NCT02192359


Ignite Creation Date: 2025-12-24 @ 2:51 PM
Ignite Modification Date: 2026-02-25 @ 9:42 PM
Study NCT ID: NCT02192359
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-14
First Post: 2014-07-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Carboxylesterase-Expressing Allogeneic Neural Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Anaplastic Astrocytoma View
None Recurrent Anaplastic Oligoastrocytoma View
None Recurrent Anaplastic Oligodendroglioma View
None Recurrent Glioblastoma View
None Recurrent Gliosarcoma View
None Recurrent Malignant Glioma View
None Recurrent WHO Grade III Glioma View
Keywords: